Targeting MCH Neuroendocrine Circuit in Lateral Hypothalamus to Protect Against Skeletal Senescence

Bin Guo,Yong Zhu,Shuai Lu,Xiangming Chen,Zhuoqun Ren,Yuqi Liu,Hao Luo,Chao Wang,Xucheng Yang,Jianxi Zhu

DOI: https://doi.org/10.1002/advs.202309951

IF: 15.1

2024-09-27

Advanced Science

Abstract:This study reveals a new neuroendocrine circuit connecting the lateral hypothalamus to bone, where MCH neurons enhance bone formation and protect against skeletal aging. Activating these neurons increases MCH levels, promoting bone marrow stromal cell differentiation and osteogenesis via MCHR1‐PKA signaling, suggesting potential therapeutic targets for osteoporosis and skeletal senescence. Neuroendocrine regulation is essential for maintaining metabolic homeostasis. However, whether neuroendocrine pathway influence bone metabolism and skeletal senescence is unelucidated. Here, a central neuroendocrine circuit is identified that directly controls osteogenesis. Using virus based tracing, this study is identified that melanin concentrating hormone (MCH) expressing neurons in the lateral hypothalamus (LH) are connected to the bone. Chemogenetic activation of MCH neurons in the LH induces osteogenesis, whereas inhibiting these neurons reduces osteogenesis. Meanwhile, MCH is released into the circulation upon chemogenetic activation of these neurons. Single cell sequencing reveals that blocking MCH neurons in the LH diminishes osteogenic differentiation of bone marrow stromal cells (BMSCs) and induces senescence. Mechanistically, MCH promotes BMSC differentiation by activating MCHR1 via PKA signaling, and activating MCHR1 by MCH agonists attenuate skeletal senescence in mice. By elucidating a brain‐bone connection that autonomously enhances osteogenesis, these findings uncover the neuroendocrinological mechanisms governing bone mass regulation and protect against skeletal senescence.

materials science, multidisciplinary,nanoscience & nanotechnology,chemistry